157 related articles for article (PubMed ID: 10965800)
1. Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero.
Fabrizi GM; Taioli F; Cavallaro T; Rigatelli F; Simonati A; Mariani G; Perrone P; Rizzuto N
Acta Neuropathol; 2000 Sep; 100(3):299-304. PubMed ID: 10965800
[TBL] [Abstract][Full Text] [Related]
2. Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation in myelin protein zero gene: short report.
Kochański A; Drac H; Jedrzejowska H; Hausmanowa-Petrusewicz I
Eur J Neurol; 2003 Sep; 10(5):547-9. PubMed ID: 12940837
[TBL] [Abstract][Full Text] [Related]
3. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
[TBL] [Abstract][Full Text] [Related]
5. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
[TBL] [Abstract][Full Text] [Related]
6. Expression of peripheral myelin protein zero in sural nerve of patients with Charcot-Marie-Tooth disease 1B.
Tachi N; Kozuka N; Ohya K; Chiba S; Sasaki K; Uyemura K
Pediatr Neurol; 2001 Jan; 24(1):33-5. PubMed ID: 11182278
[TBL] [Abstract][Full Text] [Related]
7. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met.
Senderek J; Hermanns B; Lehmann U; Bergmann C; Marx G; Kabus C; Timmerman V; Stoltenburg-Didinger G; Schröder JM
Brain Pathol; 2000 Apr; 10(2):235-48. PubMed ID: 10764043
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study.
Fabrizi GM; Tamburin S; Cavallaro T; Cabrini I; Ferrarini M; Taioli F; Magrinelli F; Zanette G
Clin Neurophysiol; 2018 Jan; 129(1):21-32. PubMed ID: 29136549
[TBL] [Abstract][Full Text] [Related]
9. Peripheral myelin modification in CMT1B correlates with MPZ gene mutations.
Lagueny A; Latour P; Vital A; Rajabally Y; Le Masson G; Ferrer X; Bernard I; Julien J; Vital C; Vandenberghe A
Neuromuscul Disord; 1999 Oct; 9(6-7):361-7. PubMed ID: 10545037
[TBL] [Abstract][Full Text] [Related]
10. A somatic and germline mosaic mutation in MPZ/P(0) mimics recessive inheritance of CMT1B.
Fabrizi GM; Ferrarini M; Cavallaro T; Jarre L; Polo A; Rizzuto N
Neurology; 2001 Jul; 57(1):101-5. PubMed ID: 11445635
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural protein zero expression in Charcot-Marie-Tooth type 1B disease.
Sindou P; Vallat JM; Chapon F; Archelos JJ; Tabaraud F; Anani T; Braund KG; Maisonobe T; Hauw JJ; Vandenberghe A
Muscle Nerve; 1999 Jan; 22(1):99-104. PubMed ID: 9883862
[TBL] [Abstract][Full Text] [Related]
12. Dysmyelinating and demyelinating Charcot-Marie-Tooth disease associated with two myelin protein zero gene mutations.
Drac H; Kabzińska D; Moszyńska I; Strugalska-Cynowska H; Hausmanowa-Petrusewicz I; Kochański A
J Appl Genet; 2011 May; 52(2):177-83. PubMed ID: 21107784
[TBL] [Abstract][Full Text] [Related]
13. Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family.
Leal A; Berghoff C; Berghoff M; Del Valle G; Contreras C; Montoya O; Hernández E; Barrantes R; Schlötzer-Schrehardt U; Neundörfer B; Reis A; Rautenstrauss B; Heuss D
Neurogenetics; 2003 Aug; 4(4):191-7. PubMed ID: 12845552
[TBL] [Abstract][Full Text] [Related]
14. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
[TBL] [Abstract][Full Text] [Related]
15. Late onset axonal Charcot-Marie-Tooth phenotype caused by a novel myelin protein zero mutation.
Bienfait HM; Faber CG; Baas F; Gabreëls-Festen AA; Koelman JH; Hoogendijk JE; Verschuuren JJ; Wokke JH; de Visser M
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):534-7. PubMed ID: 16543539
[TBL] [Abstract][Full Text] [Related]
16. Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Murakami T; Kutoku Y; Nishimura H; Hayashi M; Abe A; Hayasaka K; Sunada Y
J Neurol Sci; 2013 Nov; 334(1-2):176-9. PubMed ID: 23962696
[TBL] [Abstract][Full Text] [Related]
17. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene.
Chapon F; Latour P; Diraison P; Schaeffer S; Vandenberghe A
J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):779-82. PubMed ID: 10329755
[TBL] [Abstract][Full Text] [Related]
18. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
19. Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse.
Sidoli M; Musner N; Silvestri N; Ungaro D; D'Antonio M; Cavener DR; Feltri ML; Wrabetz L
J Neurosci; 2016 Nov; 36(44):11350-11361. PubMed ID: 27807175
[TBL] [Abstract][Full Text] [Related]
20. Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain.
Laurà M; Milani M; Morbin M; Moggio M; Ripolone M; Jann S; Scaioli V; Taroni F; Pareyson D
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1263-6. PubMed ID: 17940173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
